We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Latest Industry Insights

Female scientist standing in front of a library of microalgae cultures within Provectus Algae's biofoundry.
Industry Insight

Time To Shine: Photosynthetic Biotech Is Ripe for the Picking

Renewed efforts to tap cyanobacteria, algae and plants in arenas typically dominated by heterotrophic systems are already beginning to yield fruit. In this article, we explore the inherent value of photosynthetic biotechnologies and their challenges.
Two sharks swimming in the sea.
Industry Insight

Shark-Sourced Vaccine Ingredient May Be on Its Way Out

Shark-derived squalene is a common adjuvant product found in several approved vaccines. As calls for a sustainable source of squalene increase, researchers are exploring how yeast can be used to produce squalene analogues.
A fluorescent visual aid seen used during surgery.
Industry Insight

A Non-Invasive Treatment for Difficult-To-Treat Pediatric Brain Cancer

In this interview, Technology Networks spoke to Dr. Stuart Marcus, founder and chief medical officer of SonALAsense, to find out how ALA sonodynamic therapy could be a more effective treatment for diffuse intrinsic pontine glioma and recurrent glioblastoma.
What Do Advances in Structural Proteomics Mean for Drug Development? content piece image
Industry Insight

What Do Advances in Structural Proteomics Mean for Drug Development?

This article will cover innovations in structural proteomics, a new way to identify drug targets across the proteome, a new method to dissect drug–protein interactions and the future of structure-based drug design.
Fluid-filled LC-MS bottles.
Industry Insight

A New Era of MS-Based Proteomics To Advance Human Wellness

Technology Networks spoke to Katherine Tran from SCIEX about the latest advances in data-independent acquisition mass spectrometry and how it can be used to further our understanding of the proteome in health and disease.
A sketch depicting the idea of automation and connection in the lab.
Industry Insight

Connectivity, Flexibility and Integration in the Automated Lab

Through automating processes and workflows, scientists can optimize their time and concentrate on high-value tasks. At SLAS 2023, Technology Networks interviewed Lars Kristiansen, general manager of Agilent’s Automation Solutions Business. We discussed Agilent’s automation portfolio that was showcased at the event, in addition to trends and challenges in automation.
An image of a simulated hand touching data, a visual depiction of artificial intelligence.
Industry Insight

Automated Liquid Dispensing Supports Versatility in Biotech

Automated liquid handling methods are an attractive alternative to manual approaches, allowing labs to redirect important resources. At SLAS 2023, Technology Networks spoke with Thermo Fisher Scientific to discuss how automated liquid dispensing can support versatility in biotech.
Futuristic representation of human genomics.
Industry Insight

Probing the Biomarker Landscape of Human Disease

To find out more about the importance of improving biomarker discovery and how next-generation mass spectrometry-based systems can help to fill the current gap in biomarker technologies, Technology Networks spoke with Dr. Mo Jain.
Tower Bridge, London.
Industry Insight

The UK Is Facing a Science and Tech Exodus

In this opinion piece, Liz Sparrow discusses the real risk of the UK losing its science and technology communities as they face a series of challenges that are threatening their growth.
Vaccine vials and hypodermic needle.
Industry Insight

Lipid Impurities in mRNA: Implications and Solutions

Dr. Adam Crowe sheds light on why a newly discovered reactive impurity is detrimental to mRNA function and how it can be detected more accurately.